Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.
Xagara A, Goulielmaki M, Fortis SP, Kokkalis A, Chantzara E, Christodoulopoulos G, Samaras I, Saloustros E, Tsapakidis K, Papadopoulos V, Pateras IS, Georgoulias V, Baxevanis CN, Kotsakis A.
Xagara A, et al. Among authors: papadopoulos v.
Cancers (Basel). 2024 Jun 28;16(13):2393. doi: 10.3390/cancers16132393.
Cancers (Basel). 2024.
PMID: 39001455
Free PMC article.